X
XLinkedinWhatsAppTelegramTelegram
0
1
Read this article in:

Ceva Santé Animale given European Commission go ahead to acquire Merial assets from Boehringer Ingleheim

Deal will significantly strengthen Ceva’s European and global position, particularly in swine vaccines.

15 November 2016
X
XLinkedinWhatsAppTelegramTelegram
0
1

ceva.jpgThe European Commission recently gave its approval for the transfer to Ceva Santé Animale of nine products developed and currently marketed by Merial. The acquisition will allow Ceva to reinforce its growing presence in swine vaccines and develop its range of non-steroidal anti-inflammatory products.

To clear the way for the the acquisition of Merial animal health, from its parent company, Sanofi, Boehringer Ingelheim agreed to transfer a number of products, as well as the associated intellectual property rights, manufacturing process and R&D activity to Ceva.

For Dr. Marc Prikazsky, President and CEO of the Ceva Group: "I am very pleased that Boehringer Ingelheim chose to transfer the production and marketing of these Merial assets to Ceva. Through these products, we will inherit part of the scientific knowhow of Pasteur, Rhône-Mérieux and Merial that we will integrate into our biology business to complete the strong Hungarian heritage of our Ceva Phylaxia plant. I am proud that the European Commission has estimated that Ceva has the industrial and commercial skills to transfer and develop these ranges and accelerate development of both the biology and non-steroidal anti-inflammatory products."

Ceva will therefore gain significant share in swine biology with the addition of 4 Merial vaccines:

  • Circovac® vaccine against Porcine Circovirus type 2 (outside US)
  • Progressis® vaccine against Porcine Reproductive and Respiratory Syndrome (PRRS)
  • Parvovax® vaccine against Porcine Parvovirus
  • Parvoruvax® vaccine against Erysipelas and against Porcine Parvovirus

This acquisition includes as well the bovine vaccine Mucosiffa® and 4 non steroids anti-inflammatories:

  • Equioxx® for horse (outside US)
  • Genixine® for horse, bovine and swine
  • Ketofen® 1 % injection and tablets for dogs and cats (outside Canada)
  • Ketofen® 10 % injection horse, bovine and swine (outside Canada)

November 14, 2016 - Ceva

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list pig333.com in 3 minutes

Weekly newsletter with all the pig333.com updates

Log in and sign up on the list

Related products in the shop

The shop specialized in the pig sector
Advice and technical service
More than 120 brands and manufacturers
You are not subscribed to this list Swine News

Swine industry news in your email

Log in and sign up on the list